Oxford Nanopore sequencing solutions for cell and gene therapies

Cell and gene therapy development is inherently complex, with variability and error possible at multiple points in the process. Comprehensive sequencing serves as a critical quality control checkpoint, but many traditional methods fall short. Fragmentation and short-read assembly can obscure critical information, leaving gaps in your quality control.

In this brochure, find out how Oxford Nanopore sequencing can be applied in the development of cell and gene therapies to provide the data you need to develop better and safer therapeutics, while reducing risk.

Complete the form below to download the brochure